Diagnosis and Management of Adult Patients With Chronic Intestinal Pseudoobstruction

Abstract

Chronic intestinal pseudoobstruction (CIP) is a motility syndrome that presents with symptoms and signs of intestinal obstruction and radiographic evidence of dilated bowels, but no anatomic obstruction can be found. It primarily is a disorder of small bowel motility, but it can occur anywhere in the gastrointestinal tract. This review will focus on the diagnosis and treatment of adult patients with CIP. The clinical presentation of CIP is variable, and its incidence is rare. It is a disorder with a multitude of etiologies, many of which are poorly understood. To properly manage the patient, clinicians should be aware of the various symptoms, signs, and systemic diseases that are associated with CIP. Diagnostic studies are needed to confirm the diagnosis, identify the etiology, and search for coexisting motility dysfunction. The management goals of CIP are to restore proper nutrition and fluid balance, relieve symptoms, improve intestinal motility, and treat complications.

Get full access to this article

View all access options for this article.

References

Dudley HA, Sinclair IS, McLaren IF, McNair TJ, Newsam JE. Intestinal pseudo-obstruction. J Royal Coll Surg Edinb. 1958;3:206– 217.

Maldonado JE, Gregg JA, Green PA, Brown AL Jr. Chronic idiopathic intestinal pseudo-obstruction. Am J Med. 1970 ;49:203– 212.

Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Ped Gastroenterol Nutr. 1997 ;24:102– 112.

Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut. 1999 ;45(suppl 2):II6– II16.

Fauck DL, Anuras S, Gardner GD, Mitros FA, Summers RW, Christensen J. A familial visceral myopathy. Ann Intern Med. 1978 ;89:600– 606.

Schuffler MD, Pope CE. Studies of idiopathic intestinal pseudoobstruction, II: hereditary hollow visceral myopathy: family studies. Gastroenterology. 1977 ;73:339– 344.

Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689– 692.

Levin KH. Paraneoplastic neuromuscular syndromes. Neurol Clin. 1997;15:597– 614.

Sutton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci. 2002 ;102:475– 486.

10.

Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998 ;50:652– 657.

11.

Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991 ;100:137– 142.

12.

Briellmann RS, Sturzenegger M, Gerber HA, Schaffner T, Hess CW. Autoantibody-associated sensory neuronopathy and intestinal pseudo-obstruction without detectable neoplasia. Eur Neurol. 1996 ;36:369– 373.

13.

Lefkowitz JR, Brand DL, Schuffler MD, Brugge WR. Amyloidosis mimics achalasia's effect on lower esophageal sphincter. Dig Dis Sci. 1989;34:630– 635.

14.

Gilat T, Revach M, Sohar E. Deposition of amyloid in the gastrointestinal tract. Gut. 1969 ;10:98– 104.

15.

Tada S, Iida M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993 ;34:1412– 1417.

16.

Nowak TV, Ionasescu V, Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology. 1982 ;82:800– 810.

17.

Brunner HG, Hamel BC, Rieu P, Howeler CJ, Peters FT. Intestinal pseudo-obstruction in myotonic dystrophy. J Med Genet. 1992 ;29:791– 793.

18.

Duret RL, Bastenie PA. Intestinal disorders in hypothyroidism: clinical and manometric study. Am J Dig Dis. 1971 ;16:723– 727.

19.

Hohl RD, Nixon RK. Myxedema ileus. Arch Intern Med. 1965;115:145– 150.

20.

De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol. 2002;97:2454– 2459.

21.

Prata A. Chagas' disease. Infect Dis Clin North Am. 1994;8:61– 76.

22.

Schuffler MD, Rohrmann CA, Chaffee RG, Brand DL, Delaney JH, Young JH. Chronic intestinal pseudo-obstruction: a report of 27 cases and review of the literature. Medicine. 1981 ;60:173– 196.

23.

Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000 ;95:1456– 1462.

24.

von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc. 1992 ;67:1169– 1179.

25.

Corazza GR, Sorge M, Strocchi A, et al. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol. 1992;24:4– 9.

26.

Debinski HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut. 1997 ;41:100– 106.

27.

Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002 ;97:1113– 1126.

28.

De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004 ;16:515– 531.

29.

De Giorgio R., Guerrini S, Barbara G, et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology. 2004 ;126:1872– 1883.

30.

Abell TL. Nutrition aspects of gastroparesis and therapies for drug-refractory patients. Nutr Clin Pract. 2006 ;21:23– 33.

31.

Scolapio JS, Ukleja A, Bouras EP, Romano M. Nutritional management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol. 1999;28:306– 312.

32.

Allen JW, Ali A, Wo J, Bumpous JM, Cacchione RN. Totally laparoscopic feeding jejunostomy. Surg Endosc. 2002 ;16:1802– 1805.

33.

Tsuda K, Yokoyama Y, Morita M, Nakazawa Y, Onishi S. Selenium and chromium deficiency during long-term home PN in chronic idiopathic intestinal pseudoobstruction. Nutrition. 1998 ;14:291– 295.

34.

Buchman AL. Complications of long-term home PN: their identification, prevention and treatment. Dig Dis Sci. 2001 ;46:1– 18.

35.

Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999 ;341:137– 141.

36.

Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461– 1467.

37.

Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995;90:2147– 2151.

38.

Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation. 2003 ;76:636– 640.

39.

Grant D, Abu-Elmagd K, Reyes J, et al. 2003 Report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005 ;241:607– 613.

40.

Grant D. Intestinal transplantation: 1997 report of the international registry: Intestinal Transplant Registry. Transplantation. 1999 ;67:1061– 1064.